Pharmaceutical price regulation in Saudi Arabia: a countdown to affordable biosimilars

Posted 26/08/2016

The pricing of pharmaceuticals and biosimilars is generally subject to national regulatory control. Regulation is in place to ensure pharmaceutical affordabi...

more
Positive phase III results for Amgen’s trastuzu... Biosimilars/Research | Posted 26/08/2016
Generics in seizure control Generics/Research | Posted 26/08/2016
Biosimilars of basiliximab Biosimilars/General | Posted 26/08/2016
Janssen Biotech files lawsuits for infringement... Biosimilars/News | Posted 26/08/2016
Mylan gives up two generic drugs to allow for a... Policies & Legislation | Posted 26/08/2016
New generic versions of imatinib mesylate join... Generics/News | Posted 26/08/2016
BioProduction Congress 2016 Conferences | Posted 26/08/2016
Biosimilars North America Conferences | Posted 26/08/2016
Pharmacovigilance of biologicals in Denmark Biosimilars/Research | Posted 19/08/2016
Biosimilars of omalizumab Biosimilars/General | Posted 19/08/2016
Mylan and Biocon submit pegfilgrastim biosimila... Biosimilars/News | Posted 19/08/2016
EMA halts sales of unreliable generics Generics/General | Posted 19/08/2016
Bevacizumab similar biologics launched in India Biosimilars/News | Posted 19/08/2016
Evolution of biosimilars in developed and devel... Biosimilars/Research | Posted 19/08/2016
Launches, approvals and court cases for Sun Pharma Generics/News | Posted 19/08/2016
Biosimilars: the benefits need to be communicated Biosimilars/Research | Posted 12/08/2016
Samsung Bioepis adalimumab biosimilar submitted... Biosimilars/News | Posted 12/08/2016
Teva to acquire US-based generics maker Anda Pharma News | Posted 12/08/2016
Sandoz plans to launch five more biosimilars by... Biosimilars/General | Posted 12/08/2016
FDA approves first generic nilutamide for treat... Generics/News | Posted 12/08/2016
World Biosimilar Congress USA 2017 Conferences | Posted 12/08/2016
Biosimilars: clinicians and regulators need to... Biosimilars/Research | Posted 05/08/2016
FDA rejects Sandoz’s biosimilar pegfilgrastim a... Biosimilars/News | Posted 05/08/2016
The satisfaction of healthcare payers, patients... Generics/Research | Posted 05/08/2016
Pure red cell aplasia in a CKD patient after tr... Biosimilars/Research | Posted 05/08/2016
New proposed bipartisan legislation would cut b... Policies & Legislation | Posted 05/08/2016
Extortionate increases in prices of 32 drugs a... Generics/General | Posted 05/08/2016
FDA advisors recommend approval of Sandoz’s eta... Biosimilars/News | Posted 29/07/2016
Ways to reduce drug costs in Australia Generics/Research | Posted 29/07/2016
FDA withdraws biosimilar suffix proposal Guidelines | Posted 29/07/2016
Biosimilars of tocilizumab Biosimilars/General | Posted 29/07/2016
The economic impact of biosimilars in the US Biosimilars/Research | Posted 29/07/2016
Positive clinical data for three anti-TNF-α bio... Biosimilars/Research | Posted 29/07/2016
Teva generics being snapped up by rivals Pharma News | Posted 29/07/2016
AES position statement on substitution of gener... Generics/Research | Posted 01/07/2016
Doctors want more details in biosimilars labelling Biosimilars/Research | Posted 01/07/2016
Healthcare alliance proposes ways to reduce dru... Generics/General | Posted 01/07/2016
Mylan presents comparability data for trastuzum... Biosimilars/Research | Posted 01/07/2016
New bill would stop brand-name pharma restricti... Policies & Legislation | Posted 01/07/2016
Real-world safety data for epoetin alfa biosimilar Biosimilars/Research | Posted 01/07/2016
Global generics market expected to grow Reports | Posted 01/07/2016
Biosimilars Europe 2016 Conferences | Posted 01/07/2016
Health Canada approves Inflectra biosimilar for... Biosimilars/News | Posted 24/06/2016
more

NON-BIOLOGICAL COMPLEX DRUGS

Collaboration to introduce nanotechnologies in early stage drug development Posted 26/08/2016

The Frederick National Laboratory for Cancer Research (Frederick National Lab...

more


Iron carbohydrate follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 12/08/2016
Rigorous approach used to approve a follow-on v... Non‐Biological Complex Drugs/Research | Posted 29/07/2016
US guidelines for follow-on NBCDs Non‐Biological Complex Drugs/Guidelines | Posted 10/06/2016
Non-biological complex drugs and their follow-o... Non‐Biological Complex Drugs/Research | Posted 03/06/2016
Is a new pathway for NBCDs on the way in the US? Non‐Biological Complex Drugs/Polices & Legislation | Posted 27/05/2016
Follow-on glatiramer acetate gains European app... Non‐Biological Complex Drugs/News | Posted 13/05/2016
FDA includes follow-on versions in its new cycl... Non‐Biological Complex Drugs/Guidelines | Posted 29/04/2016
Switching between originator and follow-on iron... Non‐Biological Complex Drugs/Research | Posted 22/04/2016
Follow-on intravenous iron formulations in haem... Non‐Biological Complex Drugs/Research | Posted 01/04/2016
Glatiramoid follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 11/03/2016
FDA includes follow-on versions in its new lipo... Non‐Biological Complex Drugs/Guidelines | Posted 26/02/2016
EU guidelines for follow-on NBCDs Non‐Biological Complex Drugs/Guidelines | Posted 22/01/2016
GDUFA regulatory priorities for 2016 include co... Non‐Biological Complex Drugs/Polices & Legislation | Posted 11/12/2015
Liposomal follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 11/12/2015
Regulations for follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 13/11/2015
Status and regulatory issues surrounding follow... Non‐Biological Complex Drugs/Reports | Posted 05/11/2015
Follow-on glatiramer acetate (M356) claimed as... Non‐Biological Complex Drugs/Research | Posted 05/11/2015
EMA issues reflection paper for follow-on versi... Non‐Biological Complex Drugs/Guidelines | Posted 05/11/2015
FDA approves first follow-on version of glatira... Non‐Biological Complex Drugs/News | Posted 05/11/2015
more

Generics News Research General

more

Biosimilars News Research General

more